Registration

TREMONT STRATEGIES GROUP LLC for ELEVAR THERAPEUTICS

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA issues

LobbyistCovered position, as disclosed
LIESL GREBENSTEIN SHEEHAN New —

Medical/Disease Research/Clinical Labs MED

FDA issues

LobbyistCovered position, as disclosed
LIESL GREBENSTEIN SHEEHAN New —

Pharmacy PHA

FDA issues

LobbyistCovered position, as disclosed
LIESL GREBENSTEIN SHEEHAN New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
HLB LTD. CO. South Korea South Korea 99.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.